[go: up one dir, main page]

HK1263138A1 - Inhibition of p38 mapk for the treatment of cancer - Google Patents

Inhibition of p38 mapk for the treatment of cancer Download PDF

Info

Publication number
HK1263138A1
HK1263138A1 HK19123150.5A HK19123150A HK1263138A1 HK 1263138 A1 HK1263138 A1 HK 1263138A1 HK 19123150 A HK19123150 A HK 19123150A HK 1263138 A1 HK1263138 A1 HK 1263138A1
Authority
HK
Hong Kong
Prior art keywords
mapk
inhibition
cancer
treatment
Prior art date
Application number
HK19123150.5A
Other languages
Chinese (zh)
Inventor
Sendurai A Mani
Steven J Werden
Anurag N Paranjape
Rama Soundararajan
Natalia Sphyris
Xiaoping Sun
Saradhi Mallampati
Original Assignee
Board Of Regents, The University Of Texas System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Board Of Regents, The University Of Texas System filed Critical Board Of Regents, The University Of Texas System
Publication of HK1263138A1 publication Critical patent/HK1263138A1/en

Links

HK19123150.5A 2015-12-29 2016-12-28 Inhibition of p38 mapk for the treatment of cancer HK1263138A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62/272,394 2015-12-29
US62/272,508 2015-12-29

Publications (1)

Publication Number Publication Date
HK1263138A1 true HK1263138A1 (en) 2020-01-24

Family

ID=

Similar Documents

Publication Publication Date Title
EP3548071A4 (en) Methods for treatment of cancer comprising tigit-binding agents
EP3393475A4 (en) Methods of treating cancer
EP3286311A4 (en) Method for the treatment of malignancies
EP3256218A4 (en) Kdm1a inhibitors for the treatment of disease
EP3307240A4 (en) Combination therapy for the treatment of cancer
EP3177292A4 (en) Compounds and methods for treating cancer
IL259996A (en) Combinations for the treatment of cancer
EP3242947A4 (en) Method for the treatment of malignancies
EP3134436A4 (en) Treatment of h-ras-driven tumors
EP3490561A4 (en) Combinations for the treatment of cancer
EP3548028A4 (en) Treatment of cancer
EP3157336A4 (en) Oxabicycloheptanes and oxabicycloheptenes for the treatment of ovarian cancer
EP3226869A4 (en) Kinase inhibitor prodrug for the treatment of cancer
EP3139919A4 (en) Compounds for treatment of cancer
EP3503887A4 (en) Combinations for the treatment of cancer
EP3185910A4 (en) Methods and compositions for the treatment of cancer
EP3548007A4 (en) Methods for the treatment of cancer
EP3487999A4 (en) Methods of treating cancer
ZA201901578B (en) Combinations including abx196 for the treatment of cancer
EP3180011A4 (en) Immunotherapy for the treatment of cancer
EP3125937A4 (en) Treatment of gastric cancer
EP3303289A4 (en) Compounds and methods for treating cancer
EP3630754B8 (en) Isoindoline-acetylene compounds for the treatment of cancer
EP3674398A4 (en) Echovirus for treating tumor
EP3242681B8 (en) Novel compounds for the treatment of cancer